Going Further - Cerenovus proposes solutions to facilitate your interventions
Last update on June 16, 2022
Join Paul Bhogal and Pedro Navia as they discuss their experience treating distal clots in the M2.Learn why the novel EmboTrap Stent retriever is an ideal first choice in these anatomies. From 6.5mm to 1.5mm vessel diameter, the EmboTrap’s unique device architecture offers:
- Ease of navigation and visibility,
- Sizing simplicity and distal clot capture
- A segmented design allowing for better apposition and conformability with the vessel
- good haptic response due to the improved device architecture making it an excellent choice for combined treatments with aspiration.
IRVINE, CA – October 7, 2020 – CERENOVUS, part of Johnson & Johnson Medical Devices Companies*, today announced the European launch of CERENOVUS NIMBUS™, designed to remove tough clots for succ...
IRVINE, CA – September 9, 2020 – CERENOVUS, part of Johnson & Johnson Medical Devices Companies* today announced that it has launched CERENOVUS Stroke Solutions™, which includes a suite of thre...